alprazolam has been researched along with Anti-MuSK Myasthenia Gravis in 1 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalita, J | 1 |
| Dongre, N | 1 |
| Misra, UK | 1 |
1 other study available for alprazolam and Anti-MuSK Myasthenia Gravis
| Article | Year |
|---|---|
Myasthenic crisis due to anxiety and insomnia during COVID -19 pandemic.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety; COVID-19; Disease Progression; Humans; Male; Middle Aged; | 2020 |